The Centers for Medicare and Medicaid Services proposed in September
to expand coverage of implantable cardioverter defibrillators and positron
emission tomography (PET) for detection of Alzheimer disease.
The agency said it expects expanded coverage for implantable defibrillators
will save thousands of lives a year by increasing the number of
Medicare beneficiaries eligible for the device by one third, to nearly 500 000
The expanded coverage for PET includes Medicare patients who meet the
diagnostic criteria for both Alzheimer disease and fronto-temporal dementia
who have been evaluated for specific alternate causes of dementia and for
whom the cause of the clinical symptoms remains uncertain. Medicare coverage
of PET also includes other patients with suspected Alzheimer disease who enroll
in a large Medicare-approved clinical trial.
Mitka M. Expanding Medicare Coverage?. JAMA. 2004;292(18):2205. doi:10.1001/jama.292.18.2205-d